An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways
Jennifer R. Deuis(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Lourival D. Possani(Universidad Nacional Autónoma de México), Andrej A. Romanovsky(University of Arizona), Katharina Zimmermann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Peter J. Cabot(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands))
Cited by 169
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Overcoming Intrinsic Multidrug Resistance in Melanoma by Blocking the Mitochondrial Respiratory Chain of Slow-Cycling JARID1Bhigh Cells
|Cancer Cell|2013|680
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654